top of page
Back to Projects
Managing Obesity .jpg

Engaging Primary Care Providers and Patient Partners in Co-Developing a Provincial Pathway in the Management of Recurrent Clostridioides difficile Infection

Infectious Diseases & Immunology
2023-10-30 – 2025-03-01

Clostridioides difficile Infection (CDI) is a significant health concern in Alberta, causing symptoms from mild diarrhea to severe colon damage. Recurrent CDI (rCDI) is particularly challenging, leading to increased hospitalizations and healthcare costs. Fecal microbiota transplantation (FMT) has emerged as a highly effective treatment for rCDI, with success rates exceeding 80%. However, FMT delivery lacks standardization, is not widely accessible, and remains investigational in Canada.


To address these challenges, the PLP collaborated with the AHS Fecal Microbiota Transplant Team - Dr. Karen Wong, Dr. Dina Kao, Dr. Rose Franz - and PLP Medical Director Dr. Lynora Saxinger to develop a provincial clinical pathway for FMT. Initiated in fall 2023, the project employed a human-centred design approach to identify gaps in existing rCDI management pathways. Five process mapping sessions were conducted to adapt inpatient CDI pathways for outpatient settings.


The resulting simplified pathway underwent user testing and was revised based on feedback from primary care physicians, supported by consultants from AHS Knowledge & Evaluation, Research, and Innovation teams.


In November 2024, the revised algorithm was submitted to the Connect Care Pathway team for review, ensuring alignment with provincial electronic health record standards. The pathway is now finalized and being integrated into the Connect Care Pathway Hub.


Click here to view the pathway


This initiative aims to standardize rCDI management across Alberta, improving patient outcomes and reducing healthcare costs through timely and effective interventions.

Related to this project
Project Events
Project Tools
bottom of page